Emergent BioSolutions Inc. SEC filings EBS
Emergent BioSolutions Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 29, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 29, 2026 | Jun 26, 2026 |
| 10-Q | Quarterly report | May 1, 2026 | Mar 31, 2026 |
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 30, 2026 | Apr 29, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Apr 17, 2026 | Apr 16, 2026 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 3, 2026 | Feb 25, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 12, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 11, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Other events
|
Sep 5, 2025 | Sep 2, 2025 |
| EFFECT | Filing | Aug 15, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 23, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Other events
|
Mar 31, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 24, 2025 | — |
| 424B3 | Prospectus | Mar 24, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 24, 2025 | Mar 19, 2025 |
| DEF 14A | Proxy statement | Mar 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| POS AM | Filing | Mar 4, 2025 | — |
| POS EX | Filing | Mar 4, 2025 | — |
| 424B3 | Prospectus | Mar 4, 2025 | — |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Other events
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Dec 12, 2024 |
| EFFECT | Filing | Dec 4, 2024 | — |
| 424B3 | Prospectus | Dec 4, 2024 | — |
| CORRESP | Letter to the SEC | Dec 2, 2024 | — |
| S-1/A | Amended registration statement | Dec 2, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| S-1 | Registration statement | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
|
Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 3, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 30, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 20, 2024 | Aug 20, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Other events
|
Jul 8, 2024 | Jul 3, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jul 2, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 29, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
May 1, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 30, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2024 | Apr 23, 2024 |
| ARS | Annual report to shareholders | Apr 11, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 23, 2024 |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
|
Mar 6, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 21, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Other events
|
Jan 11, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| S-8 POS | Filing | Dec 13, 2023 | — |
| S-8 | Employee stock plan registration | Dec 11, 2023 | — |
| 10-Q | Quarterly report | Dec 11, 2023 | Sep 30, 2023 |
| 10-K/A | Amended annual report | Dec 11, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Nov 28, 2023 | Nov 21, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 24, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Restatement
|
Nov 16, 2023 | Nov 16, 2023 |
| NT 10-Q | Filing | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 5, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Other events
|
Aug 30, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 16, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Other events
|
Jul 31, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 21, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 27, 2023 | Jun 23, 2023 |
| S-8 | Employee stock plan registration | Jun 5, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 31, 2023 | May 25, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 30, 2023 | May 26, 2023 |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
May 18, 2023 | May 15, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
May 15, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| DEFR14A | Filing | Apr 24, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 17, 2023 | Apr 17, 2023 |
| ARS | Annual report to shareholders | Apr 14, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEF 14A | Proxy statement | Apr 14, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 23, 2023 | Mar 23, 2023 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 15, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2022 | Dec 6, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Sep 26, 2022 | Sep 26, 2022 |
| 8-K |
Current report
Other events
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2022 | Aug 1, 2022 |
| 10-Q | Quarterly report | Aug 2, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 6, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Agreement ended
|
Jun 7, 2022 | Jun 6, 2022 |
| 8-K |
Current report
Other events
|
Jun 6, 2022 | Jun 6, 2022 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 27, 2022 | May 26, 2022 |
| 8-K |
Current report
Material agreement
|
May 18, 2022 | May 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 10-Q | Quarterly report | Apr 29, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 28, 2022 | Apr 28, 2022 |
| DEFA14A | Additional proxy material | Apr 15, 2022 | — |
| DEF 14A | Proxy statement | Apr 15, 2022 | May 26, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 23, 2022 | Mar 17, 2022 |
| 10-K | Annual report | Feb 25, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 22, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 14, 2022 | Jan 13, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 9, 2022 |
| UPLOAD | Letter from the SEC | Dec 9, 2021 | — |
| CORRESP | Letter to the SEC | Nov 12, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2021 | Nov 11, 2021 |
| 10-Q | Quarterly report | Nov 5, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Agreement ended
|
Nov 4, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2021 | Nov 4, 2021 |
| UPLOAD | Letter from the SEC | Oct 29, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| CT ORDER | Filing | Oct 18, 2021 | — |
| 8-K |
Current report
Material agreement
|
Oct 1, 2021 | Sep 30, 2021 |
| CORRESP | Letter to the SEC | Sep 30, 2021 | — |
| 8-K/A | Amended current report | Sep 9, 2021 | Dec 8, 2016 |
| UPLOAD | Letter from the SEC | Aug 18, 2021 | — |
| S-3ASR | Automatic shelf registration | Aug 9, 2021 | — |
| 10-Q | Quarterly report | Jul 30, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2021 | Jul 20, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2021 | Jul 13, 2021 |
| S-8 | Employee stock plan registration | Jun 4, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 25, 2021 | May 20, 2021 |
| 8-K |
Current report
Other events
|
May 12, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | Apr 30, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2021 | Apr 29, 2021 |
| 8-K |
Current report
Other events
|
Apr 21, 2021 | Apr 21, 2021 |
| 8-K |
Current report
Other events
|
Apr 19, 2021 | Apr 19, 2021 |
| SEC STAFF LETTER | Filing | Apr 16, 2021 | — |
| DEFA14A | Additional proxy material | Apr 9, 2021 | — |
| DEF 14A | Proxy statement | Apr 9, 2021 | Apr 9, 2021 |
| 8-K |
Current report
Other events
|
Apr 5, 2021 | Apr 4, 2021 |
| 8-K |
Current report
Other events
|
Apr 1, 2021 | Apr 1, 2021 |
| SEC STAFF LETTER | Filing | Mar 19, 2021 | — |
| 10-K | Annual report | Feb 19, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2021 | Feb 18, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 16, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2021 | Jan 10, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EBS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Accelerated filer
- SEC CIK
- 1367644
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.